These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30742005)

  • 1. Faecal bacterial and short-chain fatty acids signature in hypercholesterolemia.
    Granado-Serrano AB; Martín-Garí M; Sánchez V; Riart Solans M; Berdún R; Ludwig IA; Rubió L; Vilaprinyó E; Portero-Otín M; Serrano JCE
    Sci Rep; 2019 Feb; 9(1):1772. PubMed ID: 30742005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and comparison of short chain fatty acids composition in gut diseases.
    Niccolai E; Baldi S; Ricci F; Russo E; Nannini G; Menicatti M; Poli G; Taddei A; Bartolucci G; Calabrò AS; Stingo FC; Amedei A
    World J Gastroenterol; 2019 Sep; 25(36):5543-5558. PubMed ID: 31576099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prebiotic Effects of Oats on Blood Lipids, Gut Microbiota, and Short-Chain Fatty Acids in Mildly Hypercholesterolemic Subjects Compared With Rice: A Randomized, Controlled Trial.
    Xu D; Feng M; Chu Y; Wang S; Shete V; Tuohy KM; Liu F; Zhou X; Kamil A; Pan D; Liu H; Yang X; Yang C; Zhu B; Lv N; Xiong Q; Wang X; Sun J; Sun G; Yang Y
    Front Immunol; 2021; 12():787797. PubMed ID: 34956218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of short-chain fatty acids and the gut microbiome with type 2 diabetes: Evidence from the Henan Rural Cohort.
    Yang T; Wu C; Li Y; Wang C; Mao Z; Huo W; Li J; Li Y; Xing W; Li L
    Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1619-1630. PubMed ID: 38653672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection.
    Brown JR; Flemer B; Joyce SA; Zulquernain A; Sheehan D; Shanahan F; O'Toole PW
    BMC Gastroenterol; 2018 Aug; 18(1):131. PubMed ID: 30153805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of SCFAs on the Parameters of the Lipid and Hepatic Profile in Pregnant Women.
    Ziętek M; Celewicz Z; Kikut J; Szczuko M
    Nutrients; 2021 May; 13(6):. PubMed ID: 34063900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal Short Chain Fatty Acids Profile is Changed in Polish Depressive Women.
    Skonieczna-Żydecka K; Grochans E; Maciejewska D; Szkup M; Schneider-Matyka D; Jurczak A; Łoniewski I; Kaczmarczyk M; Marlicz W; Czerwińska-Rogowska M; Pełka-Wysiecka J; Dec K; Stachowska E
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30544489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in fecal short chain fatty acids (SCFAs) and branched short-chain fatty acids (BCFAs) in men with benign prostatic hyperplasia (BPH) and metabolic syndrome (MetS).
    Ratajczak W; Mizerski A; Rył A; Słojewski M; Sipak O; Piasecka M; Laszczyńska M
    Aging (Albany NY); 2021 Apr; 13(8):10934-10954. PubMed ID: 33847600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome 'at-risk' population.
    Fava F; Gitau R; Griffin BA; Gibson GR; Tuohy KM; Lovegrove JA
    Int J Obes (Lond); 2013 Feb; 37(2):216-23. PubMed ID: 22410962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of gut microbiota and metabolomics in the lipid-lowering efficacy of statins among Chinese patients with coronary heart disease and hypercholesterolemia.
    Hu L; Hu B; Zhang L; Hu Y; Zhang Y; Zhang R; Yu H; Liu D; Wang X; Lin O; Gong Y; Zhang Y; Li C; Li J
    Front Cell Infect Microbiol; 2024; 14():1408581. PubMed ID: 39119290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease.
    Wang Y; Gao X; Zhang X; Xiao F; Hu H; Li X; Dong F; Sun M; Xiao Y; Ge T; Li D; Yu G; Liu Z; Zhang T
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33430702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in cardiometabolic risk markers following an oatmeal diet is associated with gut microbiota in mildly hypercholesterolemic individuals.
    Xu D; Pan D; Liu H; Yang C; Yang X; Wang X; Liu F; Feng M; Wu Q; Shen Y; Yang L; Wang S; Sun G
    Food Res Int; 2022 Oct; 160():111701. PubMed ID: 36076452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of birth mode of delivery with infant faecal microbiota, potential pathobionts, and short chain fatty acids: a longitudinal study over the first year of life.
    Mueller NT; Differding MK; Østbye T; Hoyo C; Benjamin-Neelon SE
    BJOG; 2021 Jul; 128(8):1293-1303. PubMed ID: 33338292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Oat and Tartary Buckwheat - Based Food on Cholesterol - Lowering and Gut Microbiota in Hypercholesterolemic Hamsters.
    Sun NX; Tong LT; Liang TT; Wang LL; Liu LY; Zhou XR; Zhou SM
    J Oleo Sci; 2019 Mar; 68(3):251-259. PubMed ID: 30760672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolite profiling reveals the interaction of chitin-glucan with the gut microbiota.
    Rodriguez J; Neyrinck AM; Zhang Z; Seethaler B; Nazare JA; Robles Sánchez C; Roumain M; Muccioli GG; Bindels LB; Cani PD; Maquet V; Laville M; Bischoff SC; Walter J; Delzenne NM
    Gut Microbes; 2020 Nov; 12(1):1810530. PubMed ID: 32893709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of fecal fat composition and gut derived fecal microbiota in high-fat diet fed rats following intervention with chito-oligosaccharide and resistant starch complexes.
    Shang W; Si X; Zhou Z; Li Y; Strappe P; Blanchard C
    Food Funct; 2017 Dec; 8(12):4374-4383. PubMed ID: 29068034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganoderic acid A from Ganoderma lucidum ameliorates lipid metabolism and alters gut microbiota composition in hyperlipidemic mice fed a high-fat diet.
    Guo WL; Guo JB; Liu BY; Lu JQ; Chen M; Liu B; Bai WD; Rao PF; Ni L; Lv XC
    Food Funct; 2020 Aug; 11(8):6818-6833. PubMed ID: 32686808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kefir consumption does not alter plasma lipid levels or cholesterol fractional synthesis rates relative to milk in hyperlipidemic men: a randomized controlled trial [ISRCTN10820810].
    St-Onge MP; Farnworth ER; Savard T; Chabot D; Mafu A; Jones PJ
    BMC Complement Altern Med; 2002; 2():1. PubMed ID: 11825344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barley β-glucan increases fecal bile acid excretion and short chain fatty acid levels in mildly hypercholesterolemic individuals.
    Thandapilly SJ; Ndou SP; Wang Y; Nyachoti CM; Ames NP
    Food Funct; 2018 Jun; 9(6):3092-3096. PubMed ID: 29872803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barley beta-glucans varying in molecular mass and oligomer structure affect cecal fermentation and microbial composition but not blood lipid profiles in hypercholesterolemic rats.
    Mikkelsen MS; Jensen MG; Nielsen TS
    Food Funct; 2017 Dec; 8(12):4723-4732. PubMed ID: 29165477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.